Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Description SYN-CORE Retatrutide Research Peptide SYN-CORE Retatrutide is a next-generation, multi-pathway research peptide studied for its interaction with GLP-1, GIP, and glucagon receptors
In major clinical trials, such as the landmark STEP 1 trial published in the New England Journal of Medicine , a once-weekly injection of semaglutide 2.4 mg resulted in an average body weight reduction of roughly 14.9% over 68 weeks
Improved blood sugar if applicable
Its unique triple-receptor attack fundamentally changes human energy expenditure
Avoid high-fat or heavy meals: Your stomach empties more slowly, so rich foods can sit uncomfortably
This receptor profile distinguishes Triple G (Retatrutide 6 mg) from classical incretin agonists such as semaglutide and from molecules with a dual receptor profile such as tirzepatyd
